In-hospital treatment and consequences throughout the directory hospitalization
IQR, interquartile variety; DM, diabetes mellitus; AF, atrial fibrillation; AFl, atrial flutter; CVD, cerebrovascular state; CCS, persistent coronary syndrome; CHF, chronic heart inability; CKD, persistent kidney situation; AMI, acute myocardial infarction; LL, hip and legs; EVR, endovascular revascularization; Within, antithrombotic treatment; VKA, supplement K antagonist; NOAC, the brand new oral anticoagulant; AP, antiplatelet; ACEi, angiotensin-transforming enzyme substance; ARB, angiotensin II receptor blocker.
The fresh complication costs throughout directory hospitalization presented zero somewhat apparent sex-relevant distinctions to have severe renal inability or AMI, if you find yourself each other was in fact usual when you look at the male patients immediately after many years and you can RF variations
New qualitative studies was in fact tested through a couple-sided ? dos test and the fresh new decimal investigation was basically checked out playing with a two-sided Wilcoxon test.
IQR, interquartile range; DM, diabetic issues mellitus; AF, atrial fibrillation; AFl, atrial flutter; CVD, cerebrovascular condition; CCS, chronic coronary syndrome; CHF, persistent center failure; CKD, persistent kidney condition; AMI, severe myocardial infarction; LL, lower limbs; EVR, endovascular revascularization; During the, antithrombotic treatment; VKA, supplement K antagonist; NOAC, the latest oral anticoagulant; AP, antiplatelet; ACEi, angiotensin-transforming enzyme substance; ARB, angiotensin II receptor blocker.